Globally, the burden of infectious and cardiovascular diseases continues to rise. Among U.S. African American women, the median level of high-sensitivity CRP (hs-CRP) can reach 3.2 mg/L, while in Chinese adults, approximately one-fifth of the population has elevated hs-CRP levels, indicating a widespread risk of inflammation-related diseases.
C-reactive protein (CRP) is an acute-phase reactive protein synthesized by the liver. It serves as a key serum biomarker for inflammation, infection, tissue injury, and cardiovascular risk, with its concentration increasing significantly during infection, tissue damage, or inflammatory responses.
CRP testing is widely used in clinical settings for early assessment of infections, postoperative complications, autoimmune diseases, and cardiovascular risks. In particular, high-sensitivity CRP (hs-CRP) is recognized as an important independent predictor of cardiovascular events. Rapid and accurate quantitative detection of CRP is essential for auxiliary diagnosis, evaluation of disease activity, and monitoring therapeutic efficacy.
In response to the growing global burden of inflammatory and cardiovascular diseases, healthcare institutions urgently require reliable testing tools that can provide rapid quantitative results. Get accurate CRP levels in just 3 minutes to support timely clinical decision-making.
Advantages of the CRP Quantitative Test Kit
Detection Principle: Based on quantum dot immunofluorescence technology, the test enables quantitative detection through an antigen-antibody reaction. CRP in the sample binds to fluorescence microsphere-labeled antibodies, forming a complex captured by immobilized antibodies in the detection zone. The instrument scans the fluorescence signal intensity and calculates results based on the detection-to-control ratio.
High Sensitivity and Broad Detection Range: Lower detection limit ≤ 0.5 mg/L; measuring range 0.5–200 mg/L. Covers multiple clinical intervals including normal reference values, chronic inflammation, acute bacterial infection, and severe infection. Suitable for both baseline assessment and significantly elevated pathological levels.
Rapid and Accurate Detection: Employs quantum dot immunofluorescence technology to deliver quantitative results within 3 minutes. High accuracy: relative deviation ≤ 15%, correlation coefficient r ≥ 0.990.
Excellent Stability: Within-run precision ≤ 10%; between-run precision ≤ 15%. No hook effect observed even at high concentrations. Strong anti-interference capability, suitable for hemolyzed, lipemic, and common biotin interference environments, ensuring reliable results.
Instrument Compatibility: Compatible with AFS-1000, AFS-2100, and AFS-3000B Dry Fluorescence Immunoassay Analyzers.
Multi-Sample Compatibility: Supports human serum, plasma, and whole blood samples, enabling flexible application across diverse clinical scenarios.
Simple and Efficient Operation: User-friendly procedure with minimal sample volume required. Integrated with dedicated dry fluorescence immunoassay analyzers for automated reading and analysis, reducing human error.
What applications is this test kit suitable for?
Applications: Hospital emergency testing / Physical examination centers / Scientific research / Public health screening / Cross-border procurement, etc.
We currently offer thePocTell® CRP Quantitative Test Kit (Quantum Dot Immunofluorescence), supporting bulk purchases and customized packaging.
Contact us now for tailored packaging solutions.
Tel: +86-19157876850
Email: info@innochekbiotech.com